
Adenosquamous carcinoma is a rare type of cancer with both squamous cell carcinoma (squamous) and adenocarcinoma (glandular) characteristics. The lungs, pancreas, cervix, colon, and bladder are the organs where the mixed tumour can form. Squamous cells are flat and look like skin cells, while adenocarcinoma cells form structures like glands. When both cell types exist, detection and treatment could be more complicated.
Adenosquamous carcinoma can affect various organs, and the types are usually classified based on the location of occurrence. Common types are:
Lung Adenosquamous Carcinoma: This rare variety of non-small cell lung carcinoma (NSCLC) contains squamous and adenocarcinomatous features.
Cervical Adenosquamous Carcinoma: One variety of cervical cancer that unites features of squamous cell carcinoma and adenocarcinoma is known as cervical adenosquamous carcinoma.
PancreaticAdenosquamousCarcinoma: This rare and virulent organ contains adenosquamous and squamous cell carcinoma elements.
Colorectal Adenosquamous Carcinoma is a rare form of colorectal cancer with both squamous and glandular (adenocarcinomatous) elements.
Biliary Adenosquamous Carcinoma: A bile duct malignancy containing squamous and adenocarcinomatous features.
When adenosquamous cell carcinoma is treated early, the chance of successful treatment and survival is significantly enhanced. Early detection and intervention can make surgery, chemotherapy, or radiation therapy easier to handle by preventing metastasis or the spread of the cancer to other areas of the body. Delaying treatment can aggravate the prognosis and reduce the efficacy of therapies because it raises the chances that the tumour will advance to more difficult-to-treat phases.
The general symptoms of adenosquamous carcinoma vary based on the site of the tumour.
But general symptoms can include:
Causes
Chronic inflammation and tobacco use are two variables that can raise the risk of developing adenosquamous carcinoma, and the exact causes of this type of cancer are not entirely understood.
Risk Factors
The most recent studies in India have emphasised improving the therapy of gallbladder adenosquamous carcinoma, a rare and aggressive type of cancer. Studies show progress in surgical procedures, targeted therapies, chemotherapy, radiotherapy, and early diagnosis. New tools such as immunotherapy and minimal-invasive surgery are added to therapy regimens to enhance patient results.
Surgery: Surgical resection is the primary treatment, mainly if the tumour is localised and treatable.
Chemotherapy: This treatment is often used when the cancer is advanced or spread. It reduces tumour size and controls symptoms.
Cost Start From USD 600 - USD 700Explore Options
Radiation therapy: It is applied to kill the remaining cancer cells following surgery or to cure localised tumours, especially if surgery is not feasible.
Targeted Therapy: can target cancer cells if specific genetic mutations occur.
Cost Start From USD 8000 - USD 12000Explore Options









Hyderabad, India
Apollo Hospitals located in Hyderabad, India is accredited by JCI, NABH. Also listed below are some of the most prominent infrastructural details:

Hyderabad, India
Star Hospitals located in Hyderabad, India is accredited by NABH, NABL. Also listed below are some of the most prominent infrastructural details:

Mumbai, India
Sterling Wockhardt Hospital located in Mumbai, India is accredited by NABH. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
India's advanced medical facilities, highly trained oncologists, and affordable healthcare make it among the most popular options for treating adenosquamous carcinoma. The country offers the latest diagnostic procedures, advanced therapies such as immunotherapy, and surgical expertise. Due to its many internationally recognised hospitals that provide personalised treatment, India is a sought-after option for effective and cost-saving cancer therapy.
The site of the tumour, the malignancy stage, and the treatment response all influence the prognosis of Indian patients with adenosquamous carcinoma. Early detection and treatment at advanced cancer centres can improve survival. The prognosis is less favourable if the diagnosis is delayed or occurs with metastases. Access to modern treatments such as radiation therapy, chemotherapy, and surgery in India improves outcomes.
In India, the location and site of adenosquamous carcinoma typically dictate the treatment process. Recovery might take a few weeks after a few hours of surgery. Radiation therapy usually takes 4-6 weeks, but chemotherapy usually takes 3-6 months.
The duration of immunotherapy or targeted therapy may vary depending on the patient's response and ongoing treatment schedules. In every case, the overall duration of treatment may be a few months or even longer than a year.
Depending on its primary location, adenosquamous carcinoma can spread to other organs, such as the liver, lungs, lymph nodes, and bones. In India, as in different parts of the world, cancer can metastasise if not diagnosed and treated early.
Early detection and prompt treatment at specialised cancer centres can help prevent or manage the spread of the disease to other organs, improving the chances of a better prognosis.
The following lifestyle changes can control adenosquamous carcinoma in India: consuming a well-balanced diet rich in fruits, vegetables, and whole grains to enhance immunity; exercising regularly to improve strength and power; avoiding tobacco and alcohol to reduce the risk of cancer recurrence; following stress-reduction practices such as yoga or meditation; and maintaining follow-up visits to manage treatment side effects effectively and monitor for recurrence.